The Steering Committee (SC) is a scientific and innovation-focused committee to ensure the strategic coordination and main decision-making of Inno4Vac. It is composed of 14 members representatives of the following:  

 

Composition

​

• Project coordinator: Ole Olesen, European Vaccine Initiative (EVI) 

• Industry Leader: Sandra Morel, GlaxoSmithKline (GSK)

• Scientific coordinator: Donata Medaglini, Sclavo Vaccine Association (SVA) 

• Industry Co-Leader: Simona Barzu, Sanofi Pasteur (SP) 

• EFPIA partners: Barkha Srivastava, CureVac (CureVac) and Elke Walter, Takeda (Takeda)​

​

​

Subtopics Academic Leaders & Industry Co-leaders

​

ST1

Academic Lead: Gunnveig Grodeland, University of Oslo (UiO)

Industry Co-Lead: Guglielmo Roma, GlaxoSmithKline (GSK)

​

ST2

Academic Lead: Meta Roestenberg, Leiden University Medical Center (LUMC)

Industry Co-Lead: Sandra Morel, GlaxoSmithKline (GSK)

​

ST3

Academic Lead: Cecile van Els, Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Industry Co-Lead: Martine Chabaud-Riou, Sanofi Pasteur (SP) 

​

ST4

Academic Lead: Daniel Bracewell, University College London (UCL)

Industry Co-Lead: Eric Calvosa, Sanofi Pasteur (SP) 

​

​

​